Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2

被引：0
|
作者：
Verbovoy, A. F. [1 ]
Pashentseva, A. V. [1 ]
Verbovaya, N. I. [1 ]
Madyanov, I. V. [2 ]
Sharonova, L. A. [1 ]
Galkin, R. A.
机构：
[1] Samara State Med Univ, Minist Hlth Russia, Samara, Russia
[2] Hlth Care Minist Chuvashia, Postgrad Doctors Training Inst, Cheboksary, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2018年 / 90卷 / 08期
关键词：
diabetes mellitus type 2; cardiovascular diseases; risk factors; treatment; GLYCEMIC VARIABILITY; GLUCOSE FLUCTUATIONS; VILDAGLIPTIN; COMPLICATIONS; HYPERGLYCEMIA; ASSOCIATION; GLIMEPIRIDE; STATEMENT; MORTALITY; OUTCOMES;
D O I：
10.26442/terarkh2018908113-117
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Diabetes mellitus (DM) type 2 is the serious progressing chronic disease representing independent risk factor of development of cardiovascular complications. The mortality from cardiovascular diseases at the persons suffering from DM type 2 continues to grow around the world, despite constant augmentation of expenses on treatment and prophylaxis. In this article factors of cardiovascular risk at DM are analyzed and possible ways of their correction are surveyed.
引用
收藏
页码：113 / 117
页数：5
相关论文
共 50 条
  • [41] ASSESSMENT OF CARDIOVASCULAR DISEASES RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Jose, C.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A351 - A351
  • [42] Evaluation of Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Reingold, Jason S.
    Nasir, Khurram
    Patel, Neel R.
    Pourfarzib, Ray
    Winegar, Deborah
    [J]. DIABETES, 2013, 62 : A614 - A615
  • [43] Prevention of cardiovascular risk in patients with type 2 diabetes mellitus with aspirin
    Duly-Bouhanick, B
    Menard, S
    Hadjadj, S
    Soares-Barbosa, S
    Plun-Favreau, J
    Guilloteau, G
    [J]. PRESSE MEDICALE, 2001, 30 (02): : 87 - 91
  • [44] Predictor for cardiovascular risk in patients with type-2 diabetes mellitus
    Azharuddin, Md
    Kapur, Prem
    Mishra, Ritu
    Saleem, Shakir
    Gupta, Ashok Kumar
    Adil, Mohammad
    Sharma, Manju
    [J]. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 12
  • [45] Osteprotegerin as cardiovascular risk marker in patients with type 2 diabetes mellitus
    Rozas-Moreno, P.
    Munoz-Torres, M.
    Alonso, G.
    Fernandez-Garcia, D.
    Luque-Fernandez, I.
    Sebastian-Ochoa, A.
    Escobar-Jimenez, F.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S271 - S271
  • [46] Reducing Global Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Gavin, James R., III
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2008, 108 (05): : S14 - S19
  • [47] Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
    Zeng, De-kang
    Xiao, Qian
    Li, Fa-qi
    Tang, Yu-zhi
    Jia, Chao-li
    Tang, Xue-wen
    [J]. BIOSCIENCE REPORTS, 2019, 39
  • [48] Type 2 diabetes mellitus in primary care: Control of cardiovascular risk factors
    Mantilla, T.
    Garcia Serrano, B.
    Gomez de Celis, M. I.
    Alvarez, L.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 102 - 102
  • [49] Dietary behavior patterns and cardiovascular risk factors in type 2 diabetes mellitus
    Tashtoush, RM
    Mokshagundam, SP
    Ziegler, C
    Stetson, B
    [J]. DIABETES, 2002, 51 : A620 - A620
  • [50] Control of cardiovascular risk factors in type 2 Diabetes Mellitus in primary care
    Mantilla, T
    de Oteyza, CP
    de la Cámara, AG
    de Caso, A
    Alvarez-Sala, L
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 : S210 - S210
12345